Aug 2026· Japanese Journal of Radiology· 0 citations· 94 references
Medicine
TL;DR
Recent advances in structural MRI, diffusion tensor imaging, magnetic resonance spectroscopy, quantitative susceptibility mapping, arterial spin labeling, and functional MRI for evaluating hippocampal and medial temporal lobe abnormalities in AD are summarized.
Overall, the association between cerebral metabolic dysfunction and cognitive impairment appeared to be predominantly direct, with limited evidence supporting a mediating role of regional GMV.
Shi-Qi Zhao, Jian-Wen Chen, Pei-Xue Li et al.· Frontiers in Neurology· 0 citations
Bomarker-confirmed AD comprised internally reproducible atrophy trajectories with distinct cognitive, vascular, and molecular profiles and may complement fluid biomarkers and conventional volumetry for patient stratification and prognosis.
Chen-Hui Mao, Yu-Yue Qiu, Bo Li et al.· NeuroImage· 0 citations
A practical multi-axis framework comprising clinical phenotype, AD biological context (AD pathology plus co-pathologies and molecular modifiers), network topography (regional patterns) and tempo (rate of clinical and biomarker progression) is proposed to reduce diagnostic mismatches, make cohorts more comparable and su...
L. Grinberg, M. Murray· Nature Reviews Neurology· 0 citations
While these multimodal biomarkers offer unprecedented mechanistic insights into disease progression and therapeutic response, their ultimate value depends on successful clinical translation, it would be essential for the field to prioritize standardized acquisition protocols, automated post-processing pipelines, and ac...
E. Haacke, S. Buch, Naying He et al.· NeuroImage· 0 citations
Lower static connectivity across multiple large-scale networks was associated with faster longitudinal tau accumulation and, selectively in individuals with elevated amyloid burden, with accelerated cognitive decline, and these associations were not observed for time-varying connectivity.
Mohammadali Javanray, Jonathan Gallego-Rudolf, Y. Yakoub et al.· Research Square· 0 citations
Noninvasive biomarkers are expanding access to biological assessment of Alzheimer’s disease (AD). This review evaluates blood-based, neuroimaging, retinal, electrophysiological, digital, and behavioral measures alongside structured cognitive and functional assessment, and examines multimodal and machine-learning approa...
Jun-Sheng Zhao, Cheng-Qi Nie, Rong Gao et al.· Frontiers in Cell and Develo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.